Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH)

被引:32
|
作者
Holland, Michael G. [1 ,2 ]
Schwope, David M. [3 ]
Stoppacher, Robert [4 ,5 ]
Gillen, Shane B. [5 ]
Huestis, Marilyn A. [3 ]
机构
[1] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY 13210 USA
[2] Upstate New York Poison Ctr, Syracuse, NY USA
[3] Natl Inst Drug Abuse, Intramural Res Program, NIH, Baltimore, MD USA
[4] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA
[5] Onondaga Cty Med Examiners Off, Syracuse, NY USA
基金
美国国家卫生研究院;
关键词
Postmortem redistribution; THC; Tetrahydrocannabinol; Cannabinoids; Cannabis; Marijuana; DRUG REDISTRIBUTION; DELTA-9-TETRAHYDROCANNABINOL THC; BLOOD CANNABINOIDS; PLASMA THC; MARIJUANA; URINE; TIME; PERFORMANCE; TOXICOLOGY; STABILITY;
D O I
10.1016/j.forsciint.2011.06.028
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Introduction: Postmortem redistribution (PMR), a well-described phenomenon in forensic toxicology for certain drugs, can result in increased central blood concentrations relative to peripheral blood concentrations. Delta(9)-tetrahydrocannabinol (THC), the primary psychoactive component in cannabis or marijuana, is the illicit substance most commonly implicated in driving under the influence of drugs (DUID) cases and fatally-injured drivers. No investigation of PMR of THC in human blood has been reported to date. Methods: Matched heart and iliac postmortem blood specimens were collected from 19 medical examiner cases (16 Males, 3 Females) with positive cannabinoid urine immunoassay screens. THC, its equipotent metabolite 11-hydroxy-THC (11-OH-THC) and non-psychoactive metabolite 11-nor-9-carboxy-THC (THCCOOH) were quantified by two-dimensional gas chromatography-mass spectrometry with cryofocusing, with 0.5 ng/mL limits of quantification (LOQ) for all analytes. Results: 10 cases had quantifiable THC and 11-OH-THC; THCCOOH was present in all 19. Median (range) heart: iliac blood ratios were 1.5 for THC (range: 0.3-3.1); 1.6 for 11-OH-THC (range: 0.3-2.7); and 1.8 for THCCOOH (range: 0.5-3.0). Discussion: Cannabinoids, in general, exhibited a mean and median central: peripheral (C:P) concentration ratio of less than 2 following death. A trend was observed for greater PMR with increasing postmortem interval between death and sampling. To our knowledge, these are the first data on THC PMR in humans, providing important scientific data to aid in the interpretation of postmortem cannabinoid concentrations in medico-legal investigations. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 50 条
  • [1] Postmortem Redistribution of delta-9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH)
    Holland, M. G.
    Schwope, D. M.
    Stoppacher, R.
    Gillen, S.
    Huestis, M. A.
    CLINICAL TOXICOLOGY, 2010, 48 (06) : 652 - 652
  • [2] STABILITY OF DELTA-9-TETRAHYDROCANNABINOL (THC), 11-HYDROXY-THC, AND 11-NOR-9-CARBOXY-THC IN BLOOD AND PLASMA
    JOHNSON, JR
    JENNISON, TA
    PEAT, MA
    FOLTZ, RL
    JOURNAL OF ANALYTICAL TOXICOLOGY, 1984, 8 (05) : 202 - 204
  • [3] Δ9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC
    Schwilke, Eugene W.
    Schwope, David M.
    Karschner, Erin L.
    Lowe, Ross H.
    Darwin, William D.
    Kelly, Deanna L.
    Goodwin, Robert S.
    Gorelick, David A.
    Huestis, Marilyn A.
    CLINICAL CHEMISTRY, 2009, 55 (12) : 2180 - 2189
  • [4] Implications of Plasma Δ9-Tetrahydrocannabinol, 11-Hydroxy-THC, and 11-nor-9-Carboxy-THC Concentrations in Chronic Cannabis Smokers
    Karschner, Erin L.
    Schwilke, Eugene W.
    Lowe, Ross H.
    Darwin, W. David
    Herning, Ronald I.
    Cadet, Jean Lud
    Huestis, Marilyn A.
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2009, 33 (08) : 469 - 477
  • [5] Determination of Δ-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry
    Andrenyak, David M.
    Moody, David E.
    Slawson, Matthew H.
    O'Leary, Daniel S.
    Haney, Margaret
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2017, 41 (04) : 277 - 288
  • [6] An evaluation of postmortem concentrations of Δ9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH)
    Hoffman, Melissa A.
    Trochta, Amber
    Gary, Ray D.
    Fitzgerald, Robert L.
    McIntyre, Iain M.
    FORENSIC SCIENCE INTERNATIONAL, 2020, 315
  • [7] Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma
    Karschner, Erin L.
    Barnes, Allan J.
    Lowe, Ross H.
    Scheidweiler, Karl B.
    Huestis, Marilyn A.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2010, 397 (02) : 603 - 611
  • [8] Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma
    Erin L. Karschner
    Allan J. Barnes
    Ross H. Lowe
    Karl B. Scheidweiler
    Marilyn A. Huestis
    Analytical and Bioanalytical Chemistry, 2010, 397 : 603 - 611
  • [9] Characterizing and Quantifying Extrahepatic Metabolism of (-)-Δ9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, (±)-11-Hydroxy-Δ9-THC (11-OH-THC)
    Kumar, Aditya R.
    Patilea-Vrana, Gabriela, I
    Anoshchenko, Olena
    Unadkat, Jashvant D.
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (06) : 734 - 740
  • [10] Improved and validated method for the determination of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in serum, and in human liver microsomal preparations using gas chromatography-mass spectrometry
    Steinmeyer, S
    Bregel, D
    Warth, S
    Kraemer, T
    Moeller, MR
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 772 (02): : 239 - 248